Close Menu

NEW YORK — Bioneer said on Tuesday that it has received CE-IVD marking for its AccuPower hepatitis B virus quantitative PCR kit.

In late 2018, the South Korean company received CE-IVD marking for its AccurPower RT-PCR-based HIV-1 quantitative analysis kit, and about a year later, its AccuPower RT-PCR kit for hepatitis C was CE marked. All three kits run on the company's CE-marked ExiStation system. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.

A sequencing analysis of New York City rats indicates they have adapted to the urban environment there, according to a recent preprint.

Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.

Sponsored by

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.